Expertise in
61
conditions

Dr. Andrew Hart

Oncology
Baptist Health Lagrange Kresge Pharmacy
4003 Kresge Way Ste 500, 
Louisville, KY 
Expertise in
61
conditions
Baptist Health Lagrange Kresge Pharmacy
4003 Kresge Way Ste 500, 
Louisville, KY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Andrew Hart is an Oncologist in Louisville, Kentucky. Dr. Hart is highly rated in 61 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Thrombocytopenia, Lung Cancer, and Endoscopy.

His clinical research consists of co-authoring 7 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Licenses
Internal Medicine in KY
Hospital Affiliations
Baptist Health Lagrange
Baptist Health Louisville
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Baptist Health Lagrange Kresge Pharmacy
4003 Kresge Way Ste 500, Louisville, KY 40207
Other Locations
Baptist Health Medical Group-Hematology & Oncology
2400 Eastpoint Pkwy Ste 310, Louisville, KY 40223

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Atezolizumab, Cisplatin, Fluorouracil, Gemcitabine, Mitomycin C
Study Phase: Phase 3
Phase II Study of Bladder-SparIng ChemoradiatioN With Durvalumab in Clinical Stage III, Node PosItive BladdeR CancEr (INSPIRE)
Phase II Study of Bladder-SparIng ChemoradiatioN With Durvalumab in Clinical Stage III, Node PosItive BladdeR CancEr (INSPIRE)
Enrollment Status: Active_not_recruiting
Publish Date: November 12, 2025
Intervention Type: Procedure, Biological, Drug, Other, Radiation
Study Drugs: Carboplatin, Cisplatin, Doxorubicin, Durvalumab, Gemcitabine, Methotrexate, Vinblastine, Fluorouracil, Mitomycin C
Study Phase: Phase 2
A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients With Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer Identified as Intermediate or High Risk by a 14-Gene Prognostic Assay
A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients With Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer Identified as Intermediate or High Risk by a 14-Gene Prognostic Assay
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2025
Intervention Type: Drug, Other
Study Drug: Adjuvant Chemotherapy
Study Phase: Not Applicable
View 3 Less Clinical Trials

5 Total Publications

The Practical Management of Chronic Pancreatitis: A Multidisciplinary Symposium Held at the Annual Meeting of the Pancreatic Society of Great Britain and Ireland, Manchester 2016.
The Practical Management of Chronic Pancreatitis: A Multidisciplinary Symposium Held at the Annual Meeting of the Pancreatic Society of Great Britain and Ireland, Manchester 2016.
Journal: Digestive surgery
Published: October 04, 2017
Similar Doctors
Expertise in
16
conditions
Dr. Renato V. Larocca
Oncology
Expertise in
16
conditions
Dr. Renato V. Larocca
Oncology
315 E Broadway, 
Louisville, KY 
 (6.0 miles away)
502-629-2500
Languages Spoken:
English, Italian
See accepted insurances
Accepting New Patients

Renato Larocca is an Oncologist in Louisville, Kentucky. Dr. Larocca is highly rated in 16 conditions, according to our data. His top areas of expertise are Astrocytoma, Embryonal Tumor with Multilayered Rosettes, Neuroepithelioma, and Atypical Teratoid Rhabdoid Tumor (ATRT). Dr. Larocca is currently accepting new patients.

Expertise in
74
conditions
Dr. Michael Kommor
Hematology | Oncology
Expertise in
74
conditions
Dr. Michael Kommor
Hematology | Oncology

Baptist Health Lagrange Kresge Pharmacy

4003 Kresge Way Ste 500, 
Louisville, KY 
 (2.1 miles away)
502-897-1166
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Michael Kommor is a Hematologist and an Oncologist in Louisville, Kentucky. Dr. Kommor is highly rated in 74 conditions, according to our data. His top areas of expertise are Splenic Neoplasm, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Lung Cancer.

Expertise in
21
conditions
Dr. Daniel S. Metzinger
Oncology
Expertise in
21
conditions
Dr. Daniel S. Metzinger
Oncology

University Of Louisville Physicians - Obstetrics And Gynecology - Women's Health

6420 Dutchmans Parkway, Suite 190, 
Louisville, KY 
 (0.7 miles away)
502-561-7220
Experience:
32+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Metzinger is an Oncologist in Louisville, Kentucky. Dr. Metzinger has been practicing medicine for over 32 years is highly rated in 21 conditions, according to our data. His top areas of expertise are Endometrial Cancer, Malignant Mixed Mullerian Tumor, Vulvar Cancer, Hysterectomy, and Oophorectomy. Dr. Metzinger is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hart's expertise for a condition
ConditionClose
    View All 55 Advanced Conditions
    View All 157 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile